Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemoembolization, Therapeutic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT05718232
What this trial is testing

SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH)

Who this might be right for
Advanced Hepatocellular Carcinoma
Sun Yat-sen University 136
Testing effectiveness (Phase 2)Study completedNCT02513199
What this trial is testing

Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Icahn School of Medicine at Mount Sinai 32
Large-scale testing (Phase 3)UnknownNCT05647954
What this trial is testing

HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver

Who this might be right for
Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
Taizhou Hanzhong biomedical co. LTD 350
Early research (Phase 1)Study completedNCT02724332
What this trial is testing

Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC

Who this might be right for
Hepatocellular CarcinomaRapamycin
Eastern Hepatobiliary Surgery Hospital 300
Large-scale testing (Phase 3)UnknownNCT03905967
What this trial is testing

TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma
Sun Yat-sen University 336
Large-scale testing (Phase 3)UnknownNCT04143191
What this trial is testing

Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 158
Post-approval studies (Phase 4)UnknownNCT00868569
What this trial is testing

Transhepatic Arterial Chemotherapy (TAC) Versus Transcatheter Arterial Chemoembolization (TACE) Plus Folfox4 as the Treatment of Unresectable Liver Metastasis of Colorectal Cancer

Who this might be right for
Liver MetastasisColorectal Cancer
Fudan University 200
Not applicableLooking for participantsNCT06990659
What this trial is testing

Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)

Who this might be right for
Hepato Cellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma
University Hospital, Angers 206
Testing effectiveness (Phase 2)Study completedNCT02471313
What this trial is testing

Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization

Who this might be right for
Liver CancerLiver NeoplasmHepatocellular Carcinoma+1 more
National Institutes of Health Clinical Center (CC) 3
Large-scale testing (Phase 3)Study completedNCT03636620
What this trial is testing

TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial

Who this might be right for
Hepatocellular Carcinoma
Fudan University 110
Not applicableUnknownNCT03283956
What this trial is testing

Safety and Efficacy of dRug-ElutiNg beADs Trans-arterial chemoEmbolization for Hepatocellular Carcinoma in Taiwan

Who this might be right for
Hepatocellular Carcinoma Non-resectableChemoembolization, Therapeutic
National Taiwan University Hospital 500
Testing effectiveness (Phase 2)Ended earlyNCT04653389
What this trial is testing

Perioperative Therapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 10
Testing effectiveness (Phase 2)Looking for participantsNCT07398664
What this trial is testing

H101 Plus TACE for r/m HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaOncolytic VirusTACE
West China Hospital 20
Not applicableActive Not RecruitingNCT07065786
What this trial is testing

A Generative Model-based System for Predicting Survival and Guiding Treatment Decisions in Patients With Unresectable Hepatocellularcarcinoma Undergoing Transcatheter Arterial Chemoembolization in Combination With Immunotherapy and Targeted Therapy

Who this might be right for
Transcatheter Arterial ChemoembolizationUnresectable Hepatocellular Carcinoma
Zhongda Hospital 550
Testing effectiveness (Phase 2)Study completedNCT00949182
What this trial is testing

Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Rutgers, The State University of New Jersey 20
Large-scale testing (Phase 3)UnknownNCT00921531
What this trial is testing

Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 200
Not applicableStudy completedNCT01839630
What this trial is testing

Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China

Who this might be right for
Carcinoma, Hepatocellular
Bayer 302
Large-scale testing (Phase 3)Study completedNCT00357474
What this trial is testing

Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCs

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 22
Not applicableLooking for participantsNCT06602011
What this trial is testing

Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)

Who this might be right for
Hepatocellular Carcinoma
Fujian Provincial Hospital 20
Not applicableUnknownNCT00518557
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis

Who this might be right for
Hepatocellular Carcinoma
Southeast University, China 60
Next Page